Results 201 to 210 of about 88,496 (299)

Recruitment and retention of young adults with sickle cell disease. [PDF]

Health Care Transit
Belton T, Carbaugh L, Stevens E, Seide A, Ferreira B, Teng O, Bennett L, Pfeiffer A, Ferreira M, Shova A, Arens R, Williford DN, Aygun B, Appiah-Kubi A, Apollonsky N, Boruchov D, Niss O, Smith-Whitley K, Jan S, Steinway CM.   +19 more
europepmc   +1 more source

Supporting Children With a Chronic Disease and Their Parents When Admitted to Hospital: A Scoping Review of Psychosocial Supports

Acta Paediatrica, Volume 115, Issue 7, Page 1322-1372, July 2026.
Importance of psychosocial support. ABSTRACT Aim The aim of this scoping review was to identify, examine, and summarize available evidence regarding psychosocial supports provided to children with a chronic disease when admitted to hospital and their parents. Method The JBI methodology for conducting and reporting scoping reviews was followed.
Lyndsay Jerusha MacKay, Nolan Lagrisolal, Una Chang, Matthew Christoffersen, K. Alix Hayden, Kathryn Birnie, Tammie Dewan   +6 more
wiley   +1 more source

Get screened to know your sickle cell status [French]

Get screened to know your sickle cell status [French]POUR SAVOIR SI VOUS OU VOS PROCHES e\u302tes atteints de la dre\u301panocytose ou porteurs d\u2019un ge\u300ne de la dre\u301panocytose, des tests sanguins doivent e\u302tre faits. Le fait d\u2019avoir

core  

Longitudinal Analysis of Sleep‐Disordered Breathing and Cognitive Outcomes in Children Living With Sickle Cell Anaemia

Clinical Otolaryngology, Volume 51, Issue 4, Page 520-528, July 2026.
ABSTRACT Objectives Sleep‐disordered breathing (SDB) and cognitive challenges are commonly observed in children living with sickle cell anaemia (SCA). This study investigated the longitudinal change in polysomnographic outcomes and the association with cognitive functions in children living with SCA.
Shifa Hamdule, Melanie Koelbel, Johanna C. Gavlak, Sati Sahota, Fenella J. Kirkham, Anna M. Hood   +5 more
wiley   +1 more source

Pharmacogenomics and Opioid Efficacy in Sickle Cell Disease. [PDF]

Medicina (Kaunas)
Elshaikh RH, Babker AM, Hussein SE, Ahmed KAM, Sah AK, Alfeel AH.   +5 more
europepmc   +1 more source

Academic and cerebrovascular outcomes after neurodevelopmental screening in sickle cell disease: A longitudinal cohort study

Developmental Medicine &Child Neurology, Volume 68, Issue 7, Page 916-924, July 2026.
Neurodevelopmental screening in toddlers or preschoolers with sickle cell disease (SCD) predicts future academic deficits. Screening sensitivity for future academic deficits is highest in preschoolers with SCD. Brief neurodevelopmental screening tools can identify high risk children for early intervention. This original article is commented on by Karst
Sarah E. Bills, Jeffrey Schatz, Elizabeth Gillooly, Julia D. Johnston, A. Lauren Waters, Alyssa M. Schlenz   +5 more
wiley   +1 more source

Hepatic Enzyme Abnormalities and Their Association With Hematological Parameters in Sickle Cell Disease: A Case‐Control Study in Cameroon [PDF]

Health Sci Rep
ABSTRACT Background and Aims The polymerization of deoxygenated hemoglobin S, resulting from a genetic mutation in sickle cell disease (SCD), leads to damage in multiple organs, including renal, cardiopulmonary, and cerebrovascular systems. The liver is also commonly affected, resulting in “sickle cell liver disease,” which may lead to progressive ...
Simo J, Angandji P, Tuono R, Njinjou K, Yong I, Njopwouo M, Chuisseu P.   +6 more
europepmc   +2 more sources

Suzetrigine for Vaso-Occlusive Pain in Sickle Cell Disease: A Three-Patient Case Series. [PDF]

Orthop Rev (Pavia)
Joudeh S, Moore D, Hasoon J, Robinson CL, Idowu M, Oso T.   +5 more
europepmc   +1 more source

Patient‐Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non‐Transfusion‐Dependent β‐Thalassemia Treated in the BEYOND Trial

European Journal of Haematology, Volume 117, Issue 1, Page 161-173, July 2026.
ABSTRACT In the phase 2, double‐blind, randomized controlled BEYOND trial (NCT03342404), luspatercept increased hemoglobin levels in patients with non‐transfusion‐dependent β‐thalassemia (NTDT). This study assessed long‐term effects of luspatercept on patient‐reported outcomes (PROs), using data from BEYOND and patients who continued luspatercept ...
Khaled M. Musallam, Maria Domenica Cappellini, Antonis Kattamis, Matthew Dyer, Ahmed Hnoosh, Laurie Eliason, Christopher G. Pelligra, Shien Guo, Yutian Mu, Loyse Felber Medlin, Marta Reverte, Kevin H. M. Kuo, Ali T. Taher   +12 more
wiley   +1 more source

Transcranial Doppler Ultrasound Velocity Measurements in Children With Sickle Cell Disease in Kenya. [PDF]

EJHaem
Mwalimu C, Odhiambo O, Mashisia E, Mwanja T, Ade A, De Vita MV, Oyieke K, Samia P, Kirkham F, Gwer S.   +9 more
europepmc   +1 more source